BBPvsGNOMETF Comparison
VS
Virtus LifeSci Biotech Products ETF (BBP) belongs to the Tomorrow's Treatments segment. Global X Genomics & Biotechnology ETF (GNOM) is part of the BioTech & Genomics segment. Both ETFs have the same top 3 sector exposures: and Healthcare. BBP is less expensive with a Total Expense Ratio (TER) of 0.34%, versus 0.5% for GNOM. BBP is up 21.54% year-to-date (YTD) with +$40M in YTD flows. GNOM performs worse with 18.03% YTD performance, and +$18M in YTD flows. Run a side-by-side ETF comparison of BBP and GNOM below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
BBP vs GNOM performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 07/27/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | BBP GNOM | +0.94%-5.65% | +15.67%+17.89% | +21.54%+18.03% | +56.59%+51.93% | +81.31%+13.23% | +94.15%-38.30% |
| Flows | BBP GNOM | +$10M+$7M | +$28M+$19M | +$40M+$18M | +$52M+$13M | +$55M-$95M | +$48M-$862K |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | BBP GNOM | +26.32%+28.85% | +24.02%+26.71% | +24.33%+29.11% | +26.47%+33.32% |
| Max drawdown | BBP GNOM | -7.49%-8.57% | -9.59%-18.16% | -25.54%-43.23% | -37.61%-72.01% |
| Max drawdown duration | BBP GNOM | 44d21d | 48d145d | 292d905d | 586d1789d |
Trading data
BBP | GNOM | |
Last sale 7/28/2026 at 1:30 PM | $97.69 | $53.90 |
| Previous close 07/27/2026 | $97.26 | $53.69 |
| Consolidated volume 07/27/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of June 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
BBP | GNOM | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 7/28/2026 at 1:30 PM
Live
Closed
BBP | GNOM | |
|---|---|---|
| Last price | $97.69 | $53.90 |
| 1D performance | +0.45% | +0.39% |
| AuM | $96.94 M | $78.65 M |
| E/R | 0.34% | 0.5% |
Characteristics
BBP | GNOM | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | VIRTUS Investment Partners | Global X |
| Benchmark | LifeSci Biotechnology Products Index | Solactive Genomics Index |
| N° of holdings | 66 | 50 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 16, 2014 | April 5, 2019 |
| ESG | No | No |
Advertisement
Exposure
Countries
BBP
USA
89.11%
Other
10.89%
GNOM
USA
84.1%
Other
15.9%
Sectors
BBP
Healthcare
89.47%
Other
10.53%
GNOM
Healthcare
99.75%
Other
0.25%
Advertisement
Diversification
BBP
Total weight of top 15 holdings out of 15
87.15%
GNOM
Total weight of top 15 holdings out of 15
61.22%
Top 15 holdings
Data as of June 30, 2026
BBP
Verastem, Inc.
44.58%
Legend Biotech Corp.
41.98%
Agios Pharmaceuticals, Inc.
0.05%
BioCryst Pharmaceuticals, Inc.
0.05%
BioMarin Pharmaceutical, Inc.
0.05%
Rigel Pharmaceuticals, Inc.
0.05%
Crinetics Pharmaceuticals, Inc.
0.05%
Madrigal Pharmaceuticals, Inc.
0.05%
BioNTech SE
0.05%
Iovance Biotherapeutics, Inc.
0.05%
Rhythm Pharmaceuticals, Inc.
0.05%
Alnylam Pharmaceuticals, Inc.
0.05%
Incyte Corp.
0.05%
Sarepta Therapeutics, Inc.
0.05%
Omeros Corp.
0.05%
GNOM
Guardant Health, Inc.
5.78%
Twist Bioscience Corp.
5.09%
Illumina, Inc.
4.67%
Natera, Inc.
4.41%
Moderna, Inc.
4.22%
Veracyte, Inc.
4.12%
Bio-Techne Corp.
4.08%
Vertex Pharmaceuticals, Inc.
3.85%
Legend Biotech Corp.
3.82%
10X Genomics, Inc.
3.70%
Arrowhead Pharmaceuticals, Inc.
3.67%
BioMarin Pharmaceutical, Inc.
3.59%
Praxis Precision Medicines, Inc.
3.50%
CRISPR Therapeutics AG
3.36%
QIAGEN NV
3.35%
Frequently asked questions about BBP and GNOM
How have the BBP and GNOM ETFs performed in 2026?
As of July 27, 2026, BBP is up 21.54% year-to-date (YTD), while GNOM has returned 18.03%. That puts BBP better performer ahead so far this year.
Which ETF is attracting more investor money: BBP or GNOM?
Year-to-date, the BBP ETF saw +$40M in flows, compared to +$18M for GNOM.
Which ETF is more volatile: BBP or GNOM?
Over the past year, BBP had a volatility of 24.02%, while GNOM experienced 26.71%.
Which ETF is bigger: BBP or GNOM?
As of July 27, 2026, BBP holds $96.94 M in assets under management (AUM), while GNOM manages $78.65 M.
What sectors do the BBP and GNOM ETFs invest in?
BBP leans toward sectors like Healthcare. Meanwhile, GNOM focuses on Healthcare.
What are the top holdings of the BBP ETF and GNOM ETF?
BBP top holdings include Verastem, Inc., Legend Biotech Corp. and Agios Pharmaceuticals, Inc.. GNOM holds in its top three: Guardant Health, Inc., Twist Bioscience Corp. and Illumina, Inc..
Which ETF is more diversified: BBP or GNOM?
BBP holds 66 securities with 87.15% of its assets in the top 15. GNOM has 50 securities and a top 15 weight of 61.22%.
Advertisement
Advertisement
